Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeNASDAQ:IPXL

      NASDAQ:IPXL

      Impax Laboratories Receives Tentative Approval for Generic Coreg CR Extended-Release Capsules
      Healthcare

      Impax Laboratories Receives Tentative Approval for Generic Coreg CR Extended-Release Capsules

      December 8, 2017
      Impax Laboratories Being Investigated For Merger with Amneal Pharmaceuticals
      Healthcare

      Impax Laboratories Being Investigated For Merger with Amneal Pharmaceuticals

      December 7, 2017
      Impax Laboratories Inc. Plunges 5.74% During Monday Trading
      NASDAQ

      Impax Laboratories Inc. Plunges 5.74% During Monday Trading

      November 14, 2017
      Head-to-Head: Impax Laboratories VS. SCYNEXIS
      Health

      Head-to-Head: Impax Laboratories VS. SCYNEXIS

      October 24, 2017
      Is Impax Laboratories a Buy At $16?
      Health Services

      Is Impax Laboratories a Buy At $16?

      October 20, 2017
      Impax Laboratories Inc: A Technical Snapshot
      Healthcare

      Impax Laboratories Inc: A Technical Snapshot

      October 19, 2017
      Looking Forward at Impax Laboratories Inc.
      Health

      Looking Forward at Impax Laboratories Inc.

      October 16, 2017
      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating
      Healthcare

      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

      September 26, 2017
      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC
      Healthcare

      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

      September 21, 2017
      Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval
      Health

      Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval

      June 15, 2017

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2025